Companies › TLPH
TALPHERA INC (TLPH)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001427925 · EDGAR filings · Updated 2026-06-24
TALPHERA INC (TLPH) has reported institutional ownership of 43.7%, with 45 institutional managers holding positions valued at $16.3M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-06-24 — Insider transaction reported (Form 4)
- 2026-06-24 — Insider transaction reported (Form 4)
- 2026-06-24 — Insider transaction reported (Form 4)
- 2026-06-24 — Insider transaction reported (Form 4)
- 2026-06-24 — Insider transaction reported (Form 4)
- 2026-06-24 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, TALPHERA INC has 45 institutional holders and institutional ownership of 43.7%.
Insider activity
Insiders reported 24 transactions (6 buys, 0 sells) across 12 reporting insiders, with a net reported value of $430.2K.
Data flags from SEC filings
Related companies
TUHURA BIOSCIENCES INC (HURA) · Tela Bio Inc (TELA) · XILIO THERAPEUTICS INC (XLO) · Cognition Therapeutics Inc (CGTX) · NEPHROS INC (NEPH) · ELUTIA INC (ELUT)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-24.